Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06655077 · ClinicalTrials.gov registry record · NA

Incorporating PRO Data Into RA Clinical Encounters Using Health IT

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
554
Enrollment target

NCT06655077 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 554 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06655077, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
554 participants
Enrollment target

Study Summary

The goal of this pragmatic clinical trial is to learn if a new health IT tool that was rolled out at UCSF Health rheumatology clinics (the RA PRO dashboard) can help improve the lives of individuals with rheumatoid arthritis. The RA PRO dashboard displays important outcomes for individuals with rheumatoid arthritis, including disease activity, physical functioning, and pain scores in an easy-to-read, digital interface that can be displayed on the computer screen during a clinical visit. These outcomes are tracked over time, so patients and clinicians can see changes across multiple time points. Additional features of the dashboard include displaying medication use over time and recent lab test results. The main questions the study aims to answer are: Does displaying the dashboard during a clinical visit ... 1. reduce decisional conflict when making a medication choice? 2. improve self-efficacy in symptom management? 3. change beliefs about medications? 4. improve medication adherence? 5. improve RA outcomes such as disease activity or physical functioning? Researchers will compare these outcomes in the patients of clinicians who have access to the RA PRO dashboard to those who do not to see if these outcomes change over time. Clinicians with access to the dashboard may choose to share it from the computer screen with patients during the clinic visit. Participants will be asked to complete surveys as part of their routine clinic visits.

Interventions

  • OTHER RA PRO Dashboard

Trial Details

FieldValue
Enrollment Target 554 participants
Start Date 2020-02-26
Est. Completion 2023-08-21
Phase NA

What the Registry Record Tells You About NCT06655077

The ClinicalTrials.gov registry entry for NCT06655077 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RA PRO Dashboard is the first listed.

NCT06655077 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06655077 about?

NCT06655077 is a clinical study titled "Incorporating PRO Data Into RA Clinical Encounters Using Health IT". The goal of this pragmatic clinical trial is to learn if a new health IT tool that was rolled out at UCSF Health rheumatology clinics (the RA PRO dashboard) can help improve the lives of individuals with rheumatoid arthritis. The RA PRO dashboard displays important outcomes for individuals with rheu...

What is the current status of trial NCT06655077?

This trial is currently completed. It is a NA study. The enrollment target is 554 participants. The study started on 2020-02-26. Estimated completion is 2023-08-21.

What interventions are being tested in trial NCT06655077?

The interventions under investigation include: RA PRO Dashboard (OTHER).

Who is sponsoring clinical trial NCT06655077?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.